Document:

Exhibit 4.75

March 3, 2008

 

PERSONAL &
CONFIDENTIAL

 

Mr. Jean-Pierre Robert

***

 

1.                                      EMPLOYMENT

 

Since May 8, 2005, you
have been employed with DRAXIMAGE, a division of DRAXIS Specialty
Pharmaceuticals Inc.  On July 20,
2007, you became President of DRAXIS Specialty Pharmaceuticals Inc. (“DSPI”).
As of January 1, 2008, you shall have been employed with DRAXIS Health
Inc. (“DRAXIS”) as its Chief Operating Officer. 
You also retain the office of President of DSPI on the terms and
conditions contained in this Agreement. 
You will report to the President & Chief Executive Officer of
DRAXIS.  As Chief Operating Officer of
DRAXIS and President of DSPI, you shall be responsible for DRAXIS’ and DSPI’s
day-to-day operations.  You will also be
a member of DRAXIS’ Executive Committee (“EC”) and will be expected to enter
into a cooperative working relationship with the other members of the EC.  In addition, you will perform any additional
employment responsibilities assigned to you by the President & Chief
Executive Officer of DRAXIS from time to time, provided that such
responsibilities are consistent with the executive nature of the position.

 

2.                                      BASE SALARY

 

DRAXIS will pay to you
during the term of this Agreement, effective January 1, 2008, a gross
salary of $400,000 per annum (“Base Salary”), payable semi-monthly, in arrears,
in 24 equal instalments of $16,667.  This
Base Salary will be reviewed each year thereafter, in accordance with DRAXIS’s
regular administrative practices of salary review applicable to the executive
officers of DRAXIS.  Any salary increases
shall be determined on merit on the recommendation of the President &
Chief Executive Officer of DRAXIS and approval of the Board of Directors of
DRAXIS.  The President & Chief
Executive Officer of DRAXIS will inform you of any increases, if any, in your
salary in advance of the implementation date.

 

As an officer of DRAXIS, you
will be provided and have paid for directors’ and officers’ liability insurance
and in any event DRAXIS will indemnify and save you harmless from any action
arising within the scope of your employment responsibilities for DRAXIS, and
its Affiliates (as such term is defined in the Canada
Business Corporations Act) (“Affiliates”) [hereinafter
collectively referred to as the “DRAXIS Group”]

 

3.                                      BENEFITS

 

You will be entitled to
participate in all benefit plans which the DRAXIS Group shall, from time to
time, make available to its executive employees, subject to applicable
eligibility rules thereof.  The
benefits currently offered are:

·                  major medical

 

DRAXIS HEALTH INC./SANTÉ DRAXIS INC

16751 Trans Canada Highway, Kirkland, Québec, Canada H9H 4J4 Tél: (514)
694-8220 Fax: (514) 694-8201

 

 

·                  drug

·                  dental

·                  group life

·                  short and long term
disability

·                  accidental death and
dismemberment

 

You will also be entitled to an amount of up to 5%
of your Base Salary, which exact percentage shall be determined from year to
year in lieu of participation in DRAXIS’ Retirement Savings Program (the “DRSP
Amount”).

 

4.                                      STOCK OPTION PLAN

 

Subject to DRAXIS
Board of Directors’ approval, you will be eligible to participate in the 2006
Stock Option Plan, copy thereof provided herewith as Schedule “A”, which DRAXIS
shall, from time to time, make available to employees, in accordance with the
terms and conditions of said plan.  You
have agreed to accept a payment of CDN$50,000 less applicable withholding taxes
payable as of the date hereof in lieu of granting you 50,000 DRAXIS Health
options which would have expired seven (7) years from the date of grant.

 

5.                                      DEFERRED SHARE UNIT PLAN

 

You will be
eligible to participate in DRAXIS’ Deferred Share Unit Plan, in accordance with
the terms and conditions of that plan, a copy thereof provided herewith as
Schedule “B”.  The Deferred Share Unit
Plan has been established to provide selected employees of DRAXIS and its
Affiliates with the opportunity to acquire share equivalent units convertible
to cash or common shares of DRAXIS.

 

6.                                      LONG TERM INCENTIVE PROGRAMS

 

You will retain your
eligibility to participate in the DRAXIMAGE Long Term Incentive Plan, the whole
in accordance with the terms and conditions of that plan, as described in your
employment agreement dated April 21, 2005.

 

You will also be eligible to
participate in the 2008 DRAXIS Pharma Long Term Equity Incentive Plan in
accordance with the terms set forth in Schedule “C” attached herewith.  The Grant Date for this Plan will be as of September 1,
2007.

 

7.                                      DISCRETIONARY BONUS

 

The Board of Directors of
DRAXIS, in its sole discretion and upon recommendation of the President &
Chief Executive Officer of DRAXIS, based on the Bonus and Objectives Plan that
is in force for all senior executives of DRAXIS, may declare a bonus
payable.  Such bonus payment is not
guaranteed and payment of a discretionary bonus in any prior year is not a
promise or guarantee of payment in subsequent years.  Further, to receive any discretionary bonus
payment, should one be declared, you must be actively employed on December 31st
of the calendar year for which the bonus is declared.  Actively employed does not include any period
of time for which you are receiving severance payments under this Agreement or
by application of the law.  Should a
discretionary bonus be declared, you may be eligible to receive an amount up to
a maximum equivalent to 40% of your Base Salary, or such other amount as may be
determined by the Board, in its sole discretion.

 

2

 

8.                                      MEMBERSHIPS AND PUBLICATIONS

 

DRAXIS will pay all professional memberships, dues
and levies deemed necessary by the President and Chief Executive Officer of
DRAXIS to the conduct of your position.

 

9.                                      VACATION

 

You shall be entitled to four (4) weeks
vacation per annum to be taken at a time or times acceptable to the President
and Chief Executive Officer of DRAXIS, having regard to the operations of the
business.  There shall be no vacation
time carried over from one calendar year into the following calendar year,
unless previous authorization has been received from the President and Chief
Executive Officer of DRAXIS.

 

10.                               EXPENSES

 

DRAXIS agrees that it shall reimburse you for
Automobile mileage allowance as permitted by Canada Customs and Revenue Agency,
all other reasonable traveling and other out-of-pocket expenses actually and
properly incurred in connection with your duties with DRAXIS and within the
policies that are enacted from time to time by DRAXIS with respect to executive
expenses.  For all such expenses you
agree you will furnish statements and vouchers as and when required by DRAXIS.

 

DRAXIS agrees to provide you with a BlackBerry and a
portable laptop that will remain at all time DRAXIS’s property.

 

DRAXIS will reimburse you for independent legal
counsel with respect to the review of this agreement to a maximum of $3,000
upon presentation of appropriate receipts.

 

11.                               DEDUCTIONS

 

All salary and other payments and allowances
outlined in this Agreement are subject to such withholding and deduction at
source as may be required by law.

 

12.                               EMPLOYEE’S COVENANTS

 

You agree that you shall devote the whole of your
working time, attention and ability to the business of DRAXIS and shall use
reasonable best efforts to promote the interests of DRAXIS.

 

You agree that you shall duly and diligently perform
all the duties assigned to you while in our employ and shall well and
faithfully serve DRAXIS.

 

You also agree that while employed with DRAXIS you
shall not, without the prior written consent of DRAXIS, engage or otherwise be
concerned in any other business or occupation, or become a director, officer,
agent or employee of any other entity.

 

Furthermore, you specifically agree that you shall
respect and comply with DRAXIS’s Disclosure and Insider Trading Policy, as
amended from time to time, copy thereof provided herewith as Schedule “D” to
form an integral part of this Agreement, DRAXIS’s Code of Ethics and Business
Conduct, as amended from time to time, copy thereof provided herewith as
Schedule “E” to form an integral part of this Agreement, and all and any
relevant rules and legislation, such as, without limiting the generality
of the foregoing, the rules on Insider Trading in the TSX Company Manual, the Ontario Securities Act, the 

 

3

 

Canada Business Corporations Act,  Quebec Securities Act and any applicable
U.S. legislation.  You acknowledge that
your senior position with DRAXIS will deem you an insider of DRAXIS and
therefore subject to applicable mandated insider regulatory and company share
trading policies and restrictions.

 

13.                               CONFIDENTIAL INFORMATION, NON-SOLICITATION AND
NON-COMPETITION

 

(a)         Non-Disclosure
of Confidential Information

 

As DRAXIS’s Chief Operating Officer and President of
DSPI, you acknowledge that you are creating, having access to, and require
knowledge of confidential and commercially valuable information of the DRAXIS
Group, the unauthorized use or disclosure of which could cause the DRAXIS Group
serious and irreparable damage.

 

(1)           “Confidential
Information” means all information, and all documents and other tangible things
recording any such information, relating to or useful in connection with the
business of the DRAXIS Group, whether or not a trade secret within the meaning
of the applicable law, which at the time or times concerned is not generally
known to Competitors (as defined below) and which has been or is from time to
time disclosed to or developed by you as a result of your employment with
DRAXIS.  Confidential Information
includes, but is not limited to, the following information of the DRAXIS Group:

 

	
  (i)

  	
   

  	
  new products;

  
	
  (ii)

  	
   

  	
  marketing strategies and plans;

  
	
  (iii)

  	
   

  	
  development strategies and plans;

  
	
  (iv)

  	
   

  	
  manufacturing processes and technologies;

  
	
  (v)

  	
   

  	
  research in progress and unpublished manuals or
  know how;

  
	
  (vi)

  	
   

  	
  regulatory filings;

  
	
  (vii)

  	
   

  	
  identity of and relationship with licensees,
  licensors or suppliers;

  
	
  (viii)

  	
   

  	
  finances, financial information, financial
  management systems;

  
	
  (ix)

  	
   

  	
  market research;

  
	
  (x)

  	
   

  	
  market experience with products;

  
	
  (xi)

  	
   

  	
  customer lists;

  
	
  (xii)

  	
   

  	
  compensation and benefits provided to employees;

  
	
  (xiii)

  	
   

  	
  any other research, information or documents which
  you are told or reasonably ought to know that the DRAXIS Group regards as
  proprietary or confidential; and

  
	
  (xiv)

  	
   

  	
  any legal advice provided to the DRAXIS Group, its
  officers, directors, employees or agents during the course or your employment
  and any details involving the DRAXIS Group’s position with respect to any
  litigation matter or prospective litigation matter which exists at the time
  of termination.

  

 

(2)           You
agree that you shall hold all Confidential Information in the strictest
confidence, as a fiduciary.  Without
limiting such obligation, you shall use Confidential Information only at times
and places designated by the DRAXIS Group in furtherance of the business of the
DRAXIS Group.  You shall not, except
where the DRAXIS Group otherwise provides its prior written consent or where
required by law, directly or indirectly disclose to any Person any Confidential
Information, directly or indirectly sell, give, loan or otherwise transfer any
Confidential Information or copy thereof to any Person, publish, lecture on or
display any Confidential Information to any Person or use Confidential
Information for your own benefit or the benefit of any other Person.

 

4

 

(3)           Your
obligations under this Section shall remain in effect with respect to each
item of Confidential Information until the date upon which such Confidential
Information has been publicly disclosed in a manner properly authorized by the
DRAXIS Group or otherwise has become known to Competitors without any breach of
this Section by you.

 

(4)           For
purposes of this Agreement, “Competitor” shall mean any Person which engages or
is preparing to engage, in whole or in part, in the design, development,
manufacture, marketing or sale of any products or services which compete
directly with a product or service which, during the 12 months prior to the
termination of this Agreement and your employment hereunder for any reason, the
DRAXIS Group marketed or at the time of termination of this Agreement and your
employment hereunder, is then preparing to market.

 

(5)           For
purpose of this Agreement, “Person” shall include individuals, partnerships,
associations, trusts, unincorporated organizations and corporations.

 

(b)           Non-Solicitation
and Non-Competition

 

(1)           You
acknowledge that the pharmaceutical and over-the-counter drug industries are
highly competitive businesses. You are a key executive of DRAXIS, and as a
result of your senior position, you confirm that you have acquired extensive
background in and knowledge of the DRAXIS Group’s business and the
pharmaceutical and over-the-counter drug industries in which the DRAXIS Group
operates. You further acknowledge that the DRAXIS Group develops and markets
its products on a North American and European basis. More particularly, the
DRAXIS Group develops products in Canada and in the eastern part of the United
States comprising the states of Connecticut, Florida, Delaware, Georgia, Maine,
Maryland, Massachusetts, Michigan, New Hampshire, New Jersey, New York, North
Carolina, Ohio, Pennsylvania, Rhode Island, South Carolina, Vermont, Virginia,
and West Virginia [hereinafter referred to as the “Territory”]. Accordingly,
you agree that in the course of your employment with DRAXIS, and thereafter for
a period of one year you shall not, without the prior written authorization of
the President and Chief Executive Officer of DRAXIS whether as principal, as
agent, or as an employee of, or in partnership, or association with any other
Person, in any manner whatsoever directly or indirectly:

 

	
  (i)

  	
   

  	
  become employed by or associated or affiliated
  with any Competitor of the DRAXIS Group in the Territory in a function
  dealing with a product or service, which during the twelve-month period
  immediately prior to the termination of this Agreement and your employment
  hereunder, for any reason, competed directly with a product or service of the
  DRAXIS Group;

  
	
  (ii)

  	
   

  	
  seek to employ or encourage others to employ or
  otherwise engage employees, agents or subcontractors of the DRAXIS Group (who
  are employees, agents or subcontractors on the date this Agreement
  terminated) or seek to in any way disrupt their business relationship with
  the DRAXIS Group;

  
	
  (iii)

  	
   

  	
  obtain by any means whatsoever the business of any
  Person who at the time of the termination of this Agreement and your
  employment hereunder, was a customer of the DRAXIS Group, if to obtain such
  business may result in a reduction of that Person’s business with the DRAXIS
  Group;

  
	
  (iv)

  	
   

  	
  approach any Person who at the time of the
  termination of this Agreement and your employment hereunder was a customer of
  the DRAXIS Group with the intention of soliciting or enticing the business of
  that Person away from the DRAXIS Group.

  

 

5

 

(c)           Reasonableness

 

You agree that the obligations set out in Sections 13(a) and (b) together with
your other obligations under this Agreement are reasonably necessary for the
protection of the DRAXIS Group’s proprietary and business interests and you
expressly agree that:

 

	
  (i)

  	
   

  	
  the scope of each of the covenants set out in
  Sections 13(a) and (b)
  above are in all respects, and in particular, in respect of Territory, time
  and subject matter, necessary and reasonable;

  
	
  (ii)

  	
   

  	
  given your general knowledge and experience, the
  obligations contained in this Agreement will not preclude you from becoming
  gainfully employed with other employers who are not Competitors following
  termination of this Agreement and your employment hereunder for any reason;

  
	
  (iii)

  	
   

  	
  your agreement to Sections 13(a) and (b) is a key
  incentive to DRAXIS formalizing the current terms and conditions of your
  employment.

  

 

(d)           Breach of Agreement

 

You also recognize that any breach of the terms and
conditions of this Agreement by you will result in material damage to the
DRAXIS Group, although it may be difficult for the DRAXIS Group to establish
the monetary value of such damage. You therefore agree that the DRAXIS Group
shall be entitled to injunctive relief, in addition to any other remedies
available to it, in a court of appropriate jurisdiction in the event of any
breach or threatened breach by you of any of the provisions of this Agreement.

 

14.                               TERMINATION OF EMPLOYMENT

 

(a)                                  Termination by DRAXIS For Serious Reason

 

DRAXIS may terminate this Agreement and your
employment hereunder at any time for Serious Reason, as that expression has
been interpreted pursuant to the laws of the Province of Québec, without notice and without payment of any kind of
compensation either by way of anticipated earnings or damages of any kind, it
being understood that all Base Salary, accrued vacation pay and all expense
claims with the terms of this Agreement incurred up to the date of termination
shall be payable to you.

 

(b)                                  Termination by DRAXIS Without Serious Reason and Without
Notice

 

DRAXIS may terminate this Agreement and your
employment hereunder, in its sole discretion, Without Notice and Without
Serious Reason, effective immediately upon the date you are advised of the
termination (the “Date of Termination”)

 

If your employment is terminated Without Serious
Reason and Without Notice pursuant to this Section, DRAXIS shall:

 

1)                                                              (a) if
the Date of Termination is on or prior to December 31, 2008, pay to you,
in a lump sum, pay in lieu of notice equivalent to twelve (12) months of your
then current Base Salary; or

(b) if the
Date of Termination is on January 1, 2009 or thereafter, pay to you, in a
lump sum, pay in lieu of notice equivalent to twelve (12) months of your then
Base Salary and, notwithstanding 7, an amount equal to the
bonus payment you received, if any, in the previous calendar year.

2)                                                              Pay
to you the prorated portion of the DRSP Amount to the Date of Termination if
the Date of 

 

6

 

Termination is
prior to December 31 (for example: if the Date of Termination is February 28th,
you would be entitled to the DRSP Amount owed for the previous year, if not
already paid, and the prorated portion of the DRSP Amount for the period of January 1st
to February 28th).

 

3)                                                              Pay
to you all outstanding vacation pay and any earned but unpaid Base Salary up to
the date of such termination within two weeks of the Date of Termination.

4)                                                              Reimburse
you for any business expenses incurred by you up to and including the Date of
Termination following provision by you of applicable receipts.

5)                                                              Maintain
coverage for six (6) months from the Date of Termination in the DRAXIS
benefit plan program (as set forth in Section 3), except for out of country
medical and short and long term disability which shall cease immediately upon
the Date of Termination.

 

The payment referred to in
paragraph 1, above, shall be guaranteed and shall not be subject to set off or
deduction as a result of your obtaining alternate employment following such
termination or otherwise mitigating any damages arising from such
termination.  Further, the payment
referred to in paragraph 1, above, is inclusive of all termination payments that
may be required by law, including pay in lieu of notice under the Civil Code of Québec.

 

The amounts paid to you pursuant to this paragraph
shall be subject to all required deductions.

 

Upon termination of your employment in accordance
with this Section 14(b),
you shall return to DRAXIS all stock options, and other securities which have
not vested or accrued during your employment with DRAXIS, the whole in
accordance with the terms and conditions set forth in the option agreements.

 

(c)                                  Termination Payment Following a Change of Control

 

(1)           In
accordance with section 14(c)  (2) below, if there is a Change of Control (as hereinafter
defined) you shall be entitled to the following:

 

A.                                                           The
amounts of any unpaid Base Salary earned up to and including Date of
Termination;

B.                                                             Any
unpaid vacation pay earned up to and including Date of Termination;

C.                                                             A
lump sum amount, equal to: two (2) times your then current Base Salary
immediately prior to the date of the Change of Control and a lump sum equal to
two (2) times the DRSP Amount to the Date of Termination if the Date of
Termination is prior to December 31 (for example: if the Date of
Termination is February 28th, you would be entitled to the DRSP
Amount owed for the previous year, if not already paid, and two (2) times
the prorated portion of the DRSP Amount for the period of January 1st
to February 28th);

D.                                                            The
right to exercise all DRAXIS stock options and other DRAXIS securities
including those not then otherwise exercisable as provided for below.

E.                                                              Reimburse
you for any business expenses incurred by you up to and 

 

 

7

 

including the Date of Termination following provision by you of
applicable receipts.

F.                                                              Maintain
coverage for six (6) months from the Date of Termination in the DRAXIS
benefit plan program (as set forth in Section 3), except for out of country medical and short and long term
disability which shall cease immediately upon the Date of Termination.

 

The payments referred to in
Section 14(c),
above, shall be guaranteed and shall not be subject to set off or deduction as
a result of your obtaining alternate employment following termination or
otherwise mitigating any damages arising from termination.  Further, the payment referred to in
Section 14(c)
(1) (C) above, is inclusive of all termination payments that may be
required by law, including pay in lieu of notice under the Civil Code of Québec.

 

The amounts paid to you pursuant to this paragraph shall be subject to
all required deductions.

 

For the purposes of this Agreement, a Change of Control shall be deemed
to occur in the following circumstances.

 

In
the event that at any date following the date of signature hereof:

 

(i)                                     the acquisition
by any persons acting jointly or in concert (as determined by the Securities Act (Ontario)), whether
directly or indirectly, of voting securities of the Corporation which, together
with all other voting securities of the Corporation held by such persons,
constitute in the aggregate more than 20% of all outstanding voting securities
of the Corporation;

 

(ii)                                  an
amalgamation, arrangement or other form of business combination of the
Corporation with another corporation which results in the holders of voting
securities of that other corporation holding, in the aggregate, more than 20%  of all
outstanding voting securities of the Corporation resulting from the business
combination; or

 

(iii)                               the sale,
transfer, lease or exchange of 50% or more of the property of the Corporation
to another person or corporation, other than in the ordinary course of business
of the Corporation, or to a Subsidiary.

 

and the Board of Directors of DRAXIS (the “Board of Directors”)
recommends acceptance of such offer to the Shareholders of DRAXIS (the
“Shareholders”) or, if the Board of Directors has made no recommendation, the
Shareholders have approved or accepted the proposed transaction, then any option,
including options not then otherwise exercisable held by you, shall become
immediately exercisable upon the issuance of the recommendation of the Board of
Directors or the approval or acceptance of the Shareholders, as the case may
be.

 

For greater clarity, no provision in this employment agreement shall be
deemed to supersede any provision of the Stock Option Plan of DRAXIS, as
amended from time to time, with respect to the right to exercise options held
by the employee in certain circumstances.

 

(2)           Except for the
ability to exercise all stock options upon a Change of Control as provided in
Section 14(c)(1)(E), the
payments and entitlements outlined in Section 14(c) (1) shall become due and payable if, and only if:

 

A.                                                           there has been
a Change of Control; and

 

8

 

B.                                                             within 12  months following any Change of
Control:

(i)             your employment is
terminated by DRAXIS or by any successor employer to DRAXIS, as the case may
be; or

(ii)          by its conduct as described
below, DRAXIS or any successor employer to DRAXIS, as the case may be,
constructively terminates your employment by:

·                  relocating the position
and/or location of your principal office more than 20 kilometers from the
location of your office, which is deemed to be Kirkland, Québec, on the date
immediately prior to the Change of Control, without your consent; or

·                  materially reducing your
title, reporting relationship, responsibilities or authority without your
consent; or

·                  materially reducing the
salary paid to by you by DRAXIS or the successor employer or terminating or
materially reducing the value of your benefit programs, including, but not
limited to, life insurance benefits, accidental death and dismemberment
benefits, long term disability benefits, extended health coverage and dental
benefits, which are referred to in Section 3 above;

C.                                                             And, you elect
in writing to receive the payments outlined in Section 14(c)(1).

 

(d)                                  Termination by DRAXIS Without Serious Reason upon Disability

 

If, as a result of incapacity due to physical or mental illness, you
are unable to render services of substantially the kind and nature, and
substantially to the extent required to be rendered in accordance with this
Agreement, and if such incapacity is expected to continue for a period of at
least twelve consecutive months from the date such incapacity commenced
(“Absence Date”) this Agreement may be deemed to be frustrated. Your employment
hereunder shall cease to be effective on the tenth day after written notice of
cessation of employment (“Notice of Cessation”) to you, provided that prior to
such cessation DRAXIS has been furnished with the written certification of a
qualified medical doctor designated by DRAXIS and you jointly which states that
you are and are expected to continue to be for at least twelve consecutive
months from the Absence Date, unable to render such services by reason of such
incapacity and the date upon which such incapacity commenced.  If DRAXIS and you are unable to agree on the
designation of a qualified medical doctor to make such determination, then each
party shall designate a medical doctor who, together, shall agree upon a third
qualified medical doctor to make such determination.  The decision of the third medical doctor
shall be binding on DRAXIS and you.  You
consent to submit to such examination as may be required by any such medical
doctor or doctors.

 

If your employment ceases pursuant to this Section, you shall be
entitled to receive a total amount equivalent to twelve (12) months of your
then current Base Salary, commencing on the date upon which the Notice of
Cessation is delivered and payable in 24 regular payments equivalent to your
regular semi-monthly Base Salary on the regular DRAXIS pay days. If you are in
receipt of disability benefits payable pursuant to the benefit plans described
above, then each semi-monthly payment payable by DRAXIS shall be reduced by an
amount equivalent to the disability benefits payment received during that pay
period.  Notwithstanding the cessation of
your employment pursuant to this Section, you shall be entitled to retain and
exercise, within a period of 6 months following the Notice of Cessation, all
stock options which have vested or accrued during your employment with DRAXIS.  The payments referred above are inclusive of
all termination payments that may be required by law, including pay in lieu of
notice under 

 

9

 

the Civil Code of Québec.  The amounts paid to you pursuant to this
paragraph shall be subject to all required deductions.

 

(e)                            Death

 

In the event that you should die during the term of this Agreement,
your employment shall automatically terminate. 
All salary, vacation pay and any bonus payments earned to date of death
but unpaid will be paid to your estate, however, no other payment of any
compensation either by way of anticipated earnings or damages of any kind shall
be paid and Section 14(g)
shall be applicable.

 

(f)                              Resignation and Retirement

 

You shall provide DRAXIS with three months notice, in writing, of your
resignation or your retirement from DRAXIS. 
Unless the Board of Directors of DRAXIS otherwise determines, you shall
return to DRAXIS all stock options granted to you during your employment with DRAXIS
which have not vested as of the date you cease to be an employee of DRAXIS and/
or the DRAXIS Group.

 

(g)                           No Further Notice or Compensation

 

Upon termination of your employment under this Agreement, you shall not
be entitled to any further grants of stock options nor shall you be entitled to
any further participation in any other incentive plan of the DRAXIS Group other
than as specifically set forth in this Agreement. For all purposes,
“termination of your employment” and “termination date” shall be the final day
of employment with DRAXIS, and shall not be deemed to include any period during
which you may legally be entitled to notice, termination pay or any contractual
or statutory notice period and in particular, shall not be deemed to include
the notice period identified above.

 

(h)                           Release and Discharge

 

All payments in accordance with Section 14 are subject to the execution by you of DRAXIS’ standard release
and discharge documents.

 

15.                               FAIR AND REASONABLE

 

The parties confirm that the notice requirements and pay in lieu of
notice provisions set out above in Section 14 are fair and reasonable and that no further notice or payments
of any kind are owed or required.  The
parties agree that upon any termination of this Agreement by DRAXIS or upon any
termination of this Agreement by you, that you shall have no action, cause of
action, claim, complaint or demand, either statutory or at common law, against
the DRAXIS Group or any other Person as a consequence of such termination.

 

16.                               RETURN OF PROPERTY

 

In the event your employment with DRAXIS is terminated for any reason,
including resignation or retirement, you will immediately return all DRAXIS
property in your possession or under your control.

 

17.                               PROVISIONS OPERATING FOLLOWING TERMINATION

 

Notwithstanding any termination of your employment with or without
serious reason, Sections 12, 13, 14,
15, 16, 17 and 18 and any provision of this Agreement necessary to give
it efficacy shall continue in full force and effect following such termination.

 

10

 

18.                               ACKNOWLEDGEMENT

 

You acknowledge that the DRAXIS Group shall not, for any purpose,
including in the event of a subsequent termination, be required to recognize or
take into account any prior service with your previous employers.

 

19.                               SEVERABILITY

 

If
any provision of this Agreement is determined to be invalid or unenforceable,
in whole or in part, such invalidity or unenforceability shall attach only to
such provision or part thereof and the remaining part of such provision and all
other provisions hereof shall continue in full force and effect.

 

20.                               NOTICE

 

Any notice to be given in connection with this Agreement shall be given
in writing and may be given by personal delivery or by registered mail (or by
fax if to DRAXIS) addressed to the recipient as follows:

 

	
  To:

  	
  Mr. Jean-Pierre Robert

  
	
   

  	
  ***

  
	
   

  	
   

  
	
  To:

  	
  DRAXIS
  HEALTH INC.

  
	
   

  	
  16751
  Trans-Canada Highway

  
	
   

  	
  Kirkland,
  Québec

  
	
   

  	
  H9H
  4J4

  
	
   

  	
  Attention:
  President & Chief Executive Officer

  
	
   

  	
  Fax
  No: (514) 630-7159

  
	
   

  	
   

  
	
   

  	
  And
  a copy to the General Counsel and Secretary

  
	
   

  	
  DRAXIS
  Health Inc.

  
	
   

  	
  16751
  Trans Canada Highway

  
	
   

  	
  Kirkland,
  Québec

  
	
   

  	
  H9H
  4J4

  
	
   

  	
  Fax
  No: (514) 630-7159

  

 

or such other address or individual as may be
designated by notice by either party to the other.  Any notice given by personal delivery or by
fax shall be deemed to have been given on the day of actual delivery and, if
made or given by registered mail on the third day, other than a Saturday,
Sunday or a statutory holiday in Quebec, following the deposit thereof in the
mail.

 

21.                               GOVERNING LAW

 

This Agreement shall be governed by and construed in accordance with
the laws of the Province of Québec and Canada applicable thereto.

 

22.                               LANGUAGE

 

You acknowledge having accepted that this Agreement and its Schedules
be drafted in the English language.  Vous reconnaissez avoir accepté que la présente entente
et ses annexes soient rédigées en langue anglaise.

 

11

 

23.                               BENEFIT OF AGREEMENT

 

This Agreement shall enure to the benefit of and be binding upon your
heirs, executors, administrators and legal personal representatives and the
successors and assigns of DRAXIS respectively.

 

24.                               ENTIRE AGREEMENT

 

This Agreement and its Schedules constitute the entire agreement
between the parties with respect to your terms and conditions of employment and
cancel and supersede any prior understandings and agreements between the
parties to this Agreement and between yourself and DSPI, including, without
limitation the Original Agreement dated April 21, 2005 and any amendments
thereto and any prior understandings and agreements between yourself and
DRAXIS.  There are no representations,
warranties, forms, conditions, undertakings or collateral agreements expressed,
implied or statutory between the parties other than as expressly set forth in
this Agreement and its Schedules.  You
waive any right to assert a claim based on any pre-contractual representations,
negligent, or otherwise, made by the DRAXIS Group.

 

To acknowledge that the terms of employment as expressed in this
Agreement are acceptable to you, please execute the enclosed copy of this
letter as indicated below and return it to me at your earliest opportunity.

 

	
   

  	
   

  	
   

  	
  Yours
  truly,

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
  DRAXIS HEALTH INC.

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  Per:

  	
  /s/
  Dan Brazier

  	
   

  
	
   

  	
   

  	
   

  	
  Dan
  Brazier

  	
   

  
	
   

  	
   

  	
   

  	
  President &
  Chief Executive Officer

  	
   

  
						

 

I accept the above-noted terms of employment with DRAXIS Health Inc. as
Chief Operating Officer of DRAXIS and President of DSPI, I agree to comply with
and be bound by the terms of employment outlined in this Agreement.

 

Dated at Montréal, the 6 day of March, 2008.

 

	
  /s/
  Alida Gualtieri

  	
   

  	
   

  	
  /s/ Jean-Pierre Robert

  	
   

  
	
  Witness

  	
   

  	
   

  	
  Jean-Pierre
  Robert

  	
   

  

 

 

12

 

TABLE OF CONTENTS

 

	
  1.

  	
  EMPLOYMENT

  	
  1

  
	
   

  	
   

  	
   

  
	
  2.

  	
  BASE SALARY

  	
  1

  
	
   

  	
   

  	
   

  
	
  3.

  	
  BENEFITS

  	
  1

  
	
   

  	
   

  	
   

  
	
  4.

  	
  STOCK OPTION PLAN

  	
  2

  
	
   

  	
   

  	
   

  
	
  5.

  	
  DEFERRED SHARE UNIT
  PLAN

  	
  2

  
	
   

  	
   

  	
   

  
	
  6.

  	
  LONG TERM
  INCENTIVE PROGRAMS

  	
  2

  
	
   

  	
   

  	
   

  
	
  7.

  	
  DISCRETIONARY BONUS

  	
  2

  
	
   

  	
   

  	
   

  
	
  8.

  	
  MEMBERSHIPS AND
  PUBLICATIONS

  	
  3

  
	
   

  	
   

  	
   

  
	
  9.

  	
  VACATION

  	
  3

  
	
   

  	
   

  	
   

  
	
  10.

  	
  EXPENSES

  	
  3

  
	
   

  	
   

  	
   

  
	
  11.

  	
  DEDUCTIONS

  	
  3

  
	
   

  	
   

  	
   

  
	
  12.

  	
  EMPLOYEE’S COVENANTS

  	
  3

  
	
   

  	
   

  	
   

  
	
  13.

  	
  CONFIDENTIAL
  INFORMATION, NON-SOLICITATION AND NON-COMPETITION

  	
  4

  
	
   

  	
   

  	
   

  
	
   

  	
  (a)

  	
  Non-Disclosure
  of Confidential Information

  	
  4

  
	
   

  	
  (b)

  	
  Non-Solicitation
  and Non-Competition

  	
  5

  
	
   

  	
  (c)

  	
  Reasonableness

  	
  6

  
	
   

  	
  (d)

  	
  Breach of Agreement

  	
  6

  
	
   

  	
   

  	
   

  
	
  14.

  	
  TERMINATION OF
  EMPLOYMENT

  	
  6

  
	
   

  	
   

  	
   

  
	
   

  	
  (a)

  	
  Termination
  by DRAXIS For Serious Reason

  	
  6

  
	
   

  	
  (b)

  	
  Termination
  by DRAXIS Without Serious Reason and Without Notice

  	
  6

  
	
   

  	
  (c)

  	
  Termination
  Payment Following a Change of Control

  	
  7

  
	
   

  	
  (d)

  	
  Termination by DRAXIS
  Without Serious Reason upon Disability

  	
  9

  
	
   

  	
  (e)

  	
  Death

  	
  10

  
	
   

  	
  (f)

  	
  Resignation and Retirement

  	
  10

  
	
   

  	
  (g)

  	
  No Further Notice or
  Compensation

  	
  10

  
	
   

  	
  (h)

  	
  Release and Discharge

  	
  10

  
	
   

  	
   

  	
   

  
	
  15.

  	
  FAIR
  AND REASONABLE

  	
  10

  
	
   

  	
   

  	
   

  
	
  16.

  	
  RETURN
  OF PROPERTY

  	
  10

  
	
   

  	
   

  	
   

  
	
  17.

  	
  PROVISIONS OPERATING
  FOLLOWING TERMINATION

  	
  10

  
	
   

  	
   

  	
   

  
	
  18.

  	
  ACKNOWLEDGEMENT

  	
  11

  
	
   

  	
   

  	
   

  
	
  19.

  	
  SEVERABILITY

  	
  11

  
	
   

  	
   

  	
   

  
	
  20.

  	
  NOTICE

  	
  11

  
	
   

  	
   

  	
   

  
	
  21.

  	
  GOVERNING
  LAW

  	
  11

  
	
   

  	
   

  	
   

  
	
  22.

  	
  LANGUAGE

  	
  11

  
					

 

 

	
   

  	
   

  	
   

  
	
  23.

  	
  BENEFIT
  OF AGREEMENT

  	
  12

  
	
   

  	
   

  	
   

  
	
  24.

  	
  ENTIRE
  AGREEMENT

  	
  12

  

 

DRAXIS HEALTH INC./SANTÉ DRAXIS INC

16751 Trans Canada Highway, Kirkland, Québec, Canada H9H 4J4 Tél: (514)
694-8220 Fax: (514) 694-8201

 

2Exhibit 4.76

March 6, 2008

 

 

BY PERSONAL DELIVERY

 

Ms. Alida Gualtieri

***

 

Re: Employment Agreement

 

Dear Alida:

 

Further to the recent Board of Directors, we hereby
confirm that your employment agreement with DRAXIS Health Inc. dated October 17,
2003 and amended on March 26, 2004 and January 31, 2008 (the
“Employment Agreement”) is hereby amended as follows effective January 1,
2008:

 

·                  By deleting Section 6 and
replacing it with the following Section 6:

 

The
Board of Directors of DRAXIS, in its sole discretion, and upon recommendation
of the Chief Executive Officer of DHI, based on the Bonus and Objectives Plan
that is in force for all senior executives of DHI, may declare a bonus
payable.  Such bonus payment is not
guaranteed and payment of a discretionary bonus in any prior year is not a
promise or guarantee of payment in subsequent years.  Further, to receive any discretionary bonus payment,
should one be declared, you must be employed on December 31st
of the calendar year for which the bonus is declared.  Should  a
discretionary bonus be declared, you may be eligible to receive an amount up to
a maximum equivalent to 40% of your Base Salary, or such other amount as may be
determined by the Chief Executive Officer of DHI and the Board of Directors of
DHI, in their sole discretion.

 

All of the other terms and conditions of your
Employment Agreement remain unchanged. 
We would ask that you confirm your acceptance of this modification by
signing the duplicate of this letter.

 

If you have any questions concerning this
modification, please do not hesitate to communicate with the undersigned.

 

Regards,

 

DRAXIS HEALTH
INC.

 

 

	
  /s/Dan Brazier

  	
   

  
	
   

  	
   

  
	
  Dan Brazier

  	
   

  
	
  President and CEO

  	
   

  

 

 

 

DRAXIS HEALTH INC./SANTÉ DRAXIS INC

16751 Trans Canada Highway, Kirkland, Québec, Canada H9H 4J4 Tél: (514)
694-8220 Fax: (514) 694-8201

 

 

	
  ************************************************************************************************************

  

 

I hereby confirm having read the above mentioned
modification to my employment agreement dated October 17, 2003 and amended
March 26, 2004 and January 31, 2008 and hereby confirm my acceptance
of said modification.

 

Signed this 6th day of March,
2008 at Kirkland.

 

 

	
  /s/ Alida Gualtieri

  	
   

  
	
  Alida
  Gualtieri

  	
   

  

 

 

2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00139-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00139-of-00352.parquet"}]]